Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France
SISTOLA
1 other identifier
observational
450
1 country
103
Brief Summary
The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Typical duration for all trials
103 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 15, 2008
CompletedFirst Posted
Study publicly available on registry
May 19, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedDecember 2, 2010
July 1, 2010
2.4 years
May 15, 2008
December 1, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Profile of patients treated with candesartan for heart failure
At inclusion
Secondary Outcomes (3)
Percentage of patients taking correctly its treatment : indication, contraindication, drug titration, treatment monitoring
6 and 12 months after
Percentage of patients stopping its treatment and reasons why
12 months after
Percentage of hospitalisations due to heart failure and cardiovascular deaths
12 months after
Study Arms (1)
1
Outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure
Interventions
Eligibility Criteria
Patients seen in outpatient care (private consultation or outpatient hospital consultation) at the baseline visit
You may qualify if:
- outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure
You may not qualify if:
- patients included in a clinical trial the last 30 days before consultation
- patients unable to answer the questions for linguistic or cognitive reasons
- patients who will be difficult to follow during the one year study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
- Takedacollaborator
Study Sites (103)
Research Site
Mulhouse, Alsace, France
Research Site
Bordeaux, Aquitaine Nord, France
Research Site
Dax, Aquitaine Sud, France
Research Site
Saint-Jean-de-Luz, Aquitaine Sud, France
Research Site
Tarbes, Aquitaine Sud, France
Research Site
Arras, Artois, France
Research Site
Béthune, Artois, France
Research Site
Besançon, Aube Franche Comte, France
Research Site
Langres, Aube Franche Comte, France
Research Site
Vesoul, Aube Franche Comte, France
Research Site
Clermont-Ferrand, Auvergne Stephanois, France
Research Site
Saint-Chamond, Auvergne Stephanois, France
Research Site
Saint-Etienne, Auvergne Stephanois, France
Research Site
Caen, Basse Normandie, France
Research Site
Granville, Basse Normandie, France
Research Site
Mayenne, Basse Normandie, France
Research Site
Saint-Martin-d'Aubigny, Basse Normandie, France
Research Site
Valognes, Basse Normandie, France
Research Site
Dijon, Bourgogne-Franche-Comté, France
Research Site
Dole, Bourgogne-Franche-Comté, France
Research Site
Paray-le-Monial, Bourgogne-Franche-Comté, France
Research Site
Semur-en-Auxois, Bourgogne-Franche-Comté, France
Research Site
Lannion, Bretagne Nord, France
Research Site
Rennes, Bretagne Nord, France
Research Site
Morlaix, Bretagne Sud, France
Research Site
Bry-sur-Marne, Brie, France
Research Site
Meaux, Brie, France
Research Site
Savigny-sur-Orge, Brie, France
Research Site
Béziers, Catalogne, France
Research Site
Perpignan, Catalogne, France
Research Site
Sète, Catalogne, France
Research Site
Épernay, Champagne Ardennes, France
Research Site
Château-d'Olonne, Charente, France
Research Site
Niort, Charente, France
Research Site
Poitiers, Charente, France
Research Site
Royan, Charente, France
Research Site
Annecy-le-Vieux, Dauphine, France
Research Site
Annemasse, Dauphine, France
Research Site
Sallanches, Dauphine, France
Research Site
Nice, Esterel, France
Research Site
Saint-Raphaël, Esterel, France
Research Site
Hazebrouck, Flandres, France
Research Site
Lille, Flandres, France
Research Site
Wattrelos, Flandres, France
Research Site
Castelsarrasin, Gascogne, France
Research Site
Montauban, Gascogne, France
Research Site
Périgueux, Gascogne, France
Research Site
Rouen, Haute Normandie, France
Research Site
Boulogne-Billancourt, Hauts de Seine, France
Research Site
Arles, Languedoc, France
Research Site
Montpellier, Languedoc, France
Research Site
Nîmes, Languedoc, France
Research Site
Rodez, Languedoc, France
Research Site
Villefranche-de-Rouergue, Languedoc, France
Research Site
Limoges, Limousin, France
Research Site
Saint-Amand-Montrond, Limousin, France
Research Site
Saint-Yrieix-la-Perche, Limousin, France
Research Site
Nancy, Lorraine, France
Research Site
Saint-Avold, Lorraine, France
Research Site
Bourgoin, Lyonnais, France
Research Site
Bron, Lyonnais, France
Research Site
Gleizé, Lyonnais, France
Research Site
Lyon, Lyonnais, France
Research Site
Rillieux-la-Pape, Lyonnais, France
Research Site
Cogolin, Maures Corse, France
Research Site
Hyères, Maures Corse, France
Research Site
Toulon, Maures Corse, France
Research Site
Castanet-Tolosan, Midi Pyrenees, France
Research Site
Muret, Midi Pyrenees, France
Research Site
Paris, Paris Centre, France
Research Site
Aulnay-sous-Bois, Paris Nord Est, France
Research Site
Montfermeil, Paris Nord Est, France
Research Site
Montreuil, Paris Nord Est, France
Research Site
Châteaubriant, Pays de Loire, France
Research Site
Nantes, Pays de Loire, France
Research Site
Amiens, Picardie, France
Research Site
Condé-sur-l'Escaut, Picardie, France
Research Site
Valenciennes, Picardie, France
Research Site
Allauch, Provence-Alpes-Côte d'Azur Region, France
Research Site
Marseille, Provence-Alpes-Côte d'Azur Region, France
Research Site
Rognac, Provence-Alpes-Côte d'Azur Region, France
Research Site
Salon-de-Provence, Provence-Alpes-Côte d'Azur Region, France
Research Site
La Source, Sologne, France
Research Site
Montargis, Sologne, France
Research Site
Orléans, Sologne, France
Research Site
Tonnerre, Sologne, France
Research Site
Arpajon, Touraine, France
Research Site
Chambray-lès-Tours, Touraine, France
Research Site
Tours, Touraine, France
Research Site
Villiers-sur-Orge, Touraine, France
Research Site
Apt, Vallee Du Rhone, France
Research Site
Châteaurenard, Vallee Du Rhone, France
Research Site
Gap, Vallee Du Rhone, France
Research Site
Beauchamp, Vexin, France
Research Site
Beauvais, Vexin, France
Research Site
Cergy, Vexin, France
Research Site
Chelles, Vexin, France
Research Site
Creil, Vexin, France
Research Site
Pontoise, Vexin, France
Research Site
Sarcelles, Vexin, France
Research Site
Évecquemont, Yvelines, France
Research Site
Gennevilliers, Yvelines, France
Research Site
Maisons-Laffitte, Yvelines, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephane Bouee, MD, MSc
CEMKA EVAL - Bourg La Reine - France
- STUDY CHAIR
Luc Hittinger, MD, Prof
Hôpital Henri Mondor - Service de cardiologie - Créteil - France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 15, 2008
First Posted
May 19, 2008
Study Start
January 1, 2008
Primary Completion
June 1, 2010
Study Completion
July 1, 2010
Last Updated
December 2, 2010
Record last verified: 2010-07